Immunosuppressive therapy for kidney transplant in adults (review of TA85) [ID456]: Appeal Announcement
NICE has received six appeals against the Final Appraisal Determination on the above technology from the following organisations:
- Astellas Pharma Ltd
- British Kidney Patient Association
- ESPRIT
- NHS England
- National Kidney Federation
- British Transplantation Society, British Renal Society & Renal Association (joint appeal)
The appeal hearing took place at NICE, Level 1a City Tower, Piccadilly Plaza, Manchester M1 4BT on Wednesday 30 March 2016 at 10am.
-
-
-
Astellas Pharma Ltd : Response to scrutiny letter (PDF 223 KB)
-
-
British Kidney Patient Association : Appeal letter (PDF 117 KB)
-
British Kidney Patient Association : Scrutiny letter (PDF 83 KB)
-
British Kidney Patient Association : Response to scrutiny letter (PDF 87 KB)
-
British Kidney Patient Association : Final scrutiny letter (PDF 17 KB)
-
-
-
-
-
-
-
-
-
-
National Kidney Federation : Final scrutiny letter (PDF 92 KB)
-
-
-
-
Appeal decision Appeal decision Kidney Transplantation (adults) decision letter (PDF 730 KB)
-
Appeal decision Appeal decision Kidney Transplantation (adults) decision addendum (PDF 24 KB)
This page was last updated: